Adiposity Contributes to Differences in Left Ventricular Structure and Diastolic Function with Age in Healthy Men

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 10, 2003, Pages 4884-4890

  Gates, Phillip E ^a   Gentile, Christopher L ^a   Seals, Douglas R ^a,b   Christou, Demetra D ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ADULT; AGED; AGING; ARTICLE; BODY COMPOSITION; BODY FAT; DIASTOLE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE WALL; HEART VENTRICLE REMODELING; HUMAN; HUMAN EXPERIMENT; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; THIGH;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; AGING; BLOOD PRESSURE; BODY MASS INDEX; COHORT STUDIES; DIASTOLE; HUMANS; MALE; MIDDLE AGED; THIGH; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0242288653     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030673     Document Type: Article

References (49)

1. Lakatta EG 2000 Cardiovascular aging in health. Clin Geriatr Med 16:419-44
2. Lakatta EG, Levy D 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises. II. The aging heart in health: links to heart disease. Circulation 107:346-354
3. Borkan GA, Norris AH 1977 Fat redistribution and the changing body dimensions of the adult male. Hum Biol 49:495-513
4. Borkan G A, Hults DE, Gerzof SG, Robbins AH, Silbert CK 1983 Age changes in body composition revealed by computed tomography. J Gerontol 38:673-677
5. Lauer MS, Anderson KM, Kannel WB, Levy D1991 The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266:231-236
6. Crisostomo LL, Araujo LM, Camara E, Carvalho C, Silva FA, Vieira M, Mendes CM, Rabelo Junior A 2001 Left ventricular mass and function in young obese women. Int J Obes Relat Metab Disord 25:233-238
7. Grandi AM, Zanzi P, Piantanida E, Gaudio G, Bertolini A, Guasti L, Venco A 2000 Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly diagnosed never-treated hypertensives. Int J Obes Relat Metab Disord 24:954-958
8. Iacobellis G, Ribaudo MC, Leto G, Zappaterreno A, Vecci E, Di Mario U, Leonetti F 2002 Influence of excess fat on cardiac morphology and function: study in uncomplicated obesity. Obes Res 10:767-773
9. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB 2002 Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 76:743-749
10. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB 2002 Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 162:1867-1872
11. Montague CT, O'Rahilly S 2000 The perils of portliness: causes and consequences of visceral adiposity. Diabetes 49:883-888
12. Van Pelt RE, Davy KP, Stevenson ET, Wilson TM, Jones PP, Desouza CA, Seals DR 1998 Smaller differences in total and regional adiposity with age in women who regularly perform endurance exercise. Am J Physiol 275:E626-634
13. Kamel EG, McNeill G, Han TS, Smith FW, Avenell A, Davidson L, Tothill P 1999 Measurement of abdominal fat by magnetic resonance imaging, dual-energy x-ray absorptiometry and anthropometry in non-obese men and women. Int J Obes Relat Metab Disord 23:686-692
14. Park YW, Heymsfield SB, Gallagher D 2002 Are dual-energy x-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord 26:978-983
15. Snijder MB, Visser M, Dekker JM, Seidell JC, Fuerst T, Tylavsky F, Cauley J, Lang T, Nevitt M, Harris TB 2002 The prediction of visceral fat by dual-energy x-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord 26:984-993
16. Sahn DJ, DeMaria A, Kisslo J, Weyman A 1978 Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072-1083
17. Devereux RB, Reichek N 1977 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55:613-618
18. George KP, Batterham AM, Jones B 1998 The impact of scalar variable and process on athlete-control comparisons of cardiac dimensions. Med Sci Sports Exerc 30:824-830
19. Batterham AM, George KP 1998 Modelling the influence of body size and composition on M-mode echocardiographic dimensions. Am J Physiol 274: H701-H708
20. Devereux RB, Roman MJ 1999 Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 22:1-9
21. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET, Fabsitz RR, Howard BV 1998 Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 98:2538-2544
22. Morricone L, Malavazos AE, Coman C, Donati C, Hassan T, Caviezel F 2002 Echocardiographic abnormalities in normotensive obese patients: relationship with visceral fat. Obes Res 10:489-498
23. Mitchell BM, Gutin B, Kapuku G, Barbeau P, Humphries MC, Owens S, Vemulapalli S, Allison J 2002 Left ventricular structure and function in obese adolescents: relations to cardiovascular fitness, percent body fat, and visceral adiposity, and effects of physical training. Pediatrics 109:E73-E73
24. Humphries MC, Gutin B, Barbeau P, Vemulapalli S, Allison J, Owens S 2002 Relations of adiposity and effects of training on the left ventricle in obese youths. Med Sci Sports Exerc 34:1428-1435
25. Hinderliter A, Sherwood A, Gullette EC, Babyak M, Waugh R, Georgiades A, Blumenthal JA 2002 Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension. Arch Intern Med 162:1333-1339
26. de Simone G, Palmieri V, Bella JN, Celentano A, Hong Y, Oberman A, Kitzman DW, Hopkins PN, Arnett DK, Devereux RB 2002 Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study. J Hypertens 20:323-331
27. Palmieri V, de Simone G, Arnett DK, Bella JN, Kitzman DW, Oberman A, Hopkins PN, Province MA, Devereux RB 2001 Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol 88:1163-1168
28. Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P 2000 Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8:337-341
29. Umemura S, Nyui N, Tamura K, Hibi K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M 1997 Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 10:629-633
30. Cooper R, Forrester T, Ogunbiyi O, Muffinda J 1998 Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16:571-575
31. Harp JB, Henry SA, DiGirolamo M 2002 Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 10:985-990
32. Tuck ML, Sowers J, Dornfeld L, Kledzik G, Maxwell M 1981 The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304:930-933
33. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F 2002 Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381-388
34. Giacchetti G, Faloia E, Sardu C, Camilloni MA, Mariniello B, Gatti C, Garrapa GG, Guerrieri M, Mantero F 2000 Gene expression of angiotensinogen in adipose tissue of obese patients. Int J Obes Relat Metab Disord 24(Suppl 2):S142-S143
35. van Harmelen V, Elizalde M, Ariapart P, Bergstedt-Lindqvist S, Reynisdottir S, Hoffstedt J, Lundkvist I, Bringman S, Amer P 2000 The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 24:673-678
36. Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J 2001 Systemic infusion of angiotensin II into normal rats activa tes nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 158:1743-1756
37. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Mezzano S, Egido J 2001 Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator. Contrib Nephrol 135:123-137
38. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J 2001 Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 38:1382-1387
39. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, Egido J 2001 Angiotensin II activates nuclear transcription factor-κB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice. Nephrol Dial Transplant 16(Suppl 1):27-33
40. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J 2001 Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 10:321-329
41. Lijnen P, Petrov V 1999 Antagonism of the renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. Methods Find Exp Clin Pharmacol 21:363-374
42. Schneider MD 2002 Serial killer: angiotensin drives cardiac hypertrophy via TGF-β1. J Clin Invest 109:715-716
43. Tanaka H, Desouza CA, Jones PP, Stevenson ET, Davy KP, Seals DR 1997 Greater rate of decline in maximal aerobic capacity with age in physically active vs. sedentary healthy women. J Appl Physiol 83:1947-1953
44. Eskurza I, Donato AJ, Moreau KL, Seals DR, Tanaka H 2002 Changes in maximal aerobic capacity with age in endurance-trained women: 7-yr followup. J Appl Physiol 92:2303-2308
45. Schiller BC, Casas YG, Desouza CA, Seals DR 2001 Maximal aerobic capacity across age in healthy Hispanic and Caucasian women. J Appl Physiol 91: 1048-1054
46. Ramhamadany E, Dasgupra P, Brigden G, Lahiri A, Raftery EB, Baird IM 1989 Cardiovascular changes in obese subjects on very low calorie diet. Int J Obes 13(Suppl 2):95-99
47. Kanoupakis E, Michaloudis D, Fraidakis O, Parthenakis F, Vardas P, Melissas J 2001 Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity. Obes Surg 11:552-558
48. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, Hashimi MW, Mukerji V 1995 Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 76:1194-1197
49. Alpert MA, Lambert CR, Terry BE, Kelly DL, Panayiotou H, Mukerji V, Massey CV, Cohen MV 1994 Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients. Am J Cardiol 73:918-921